Xiaole C

Q: What is Xiaole C email address?

Email Xiaole C at xiaole@20n.bio. This email is the most updated Xiaole C's email found in 2026.

Q: How to contact Xiaole C?

To contact Xiaole C send an email to xiaole@20n.bio.

Director at 20n Bio | Greater Philadelphia, United States

Profile last verified August 2026

Biotechnology Verified Profile Greater Philadelphia, United States National University of Singapore

Xiaole C’s Email & Phone Number

Verified

Personal Email

***@yahoo.com

Personal • High Confidence

Phone Number

484*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Xiaole C Work Experience

Director at 20n Bio in October 2021 - Present

Associate Director at NovaRock Biotherapeutics Ltd in June 2019 - October 2021

Technical Account Manager at GenScript in September 2017 - February 2019

See more See less

Senior Scientist at Abzyme Therapeutics in December 2015 - September 2017

Research Assistant & Postdoc Research Fellow at Thomas Jefferson University in January 2003 - January 2015

PhD Research Scholar/ Visiting Scientist at Life Technologies in January 1999 - January 1999

Xiaole C Education

National University of Singapore, Doctor of Philosophy (Ph.D.)

Xiamen University, Bachelor's degree

Fudan University, Master's degree

Xiaole C Skills

Immunogenicity Pre-clinical Studies Research and Development (R&D) Regulatory Submissions Biologics Molecular Biology Antibody Discovery Antibody Engineering Assay Development Biochemistry

See more See less

Cell Biology Molecular Cloning PCR qPCR ELISA Flow Cytometry Confocal Microscopy Polymerase Chain Reaction (PCR) Protein Expression Protein Purification Cell Culture Immunology Cancer Biology Immunoassays Immunofluorescence immunoprecipitation Receptor trafficking Transfection adenovirus vector siRNA Autophagy Hedgehog Cell signaling Yeast two-hybrid Yeast Genomics Immunoassay CRISPR Antibody display Yeast dispaly Next generation sequencing

About Xiaole C’s Current Company

20n Bio

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging high-throughput screening and computing to generate peptide drugs with desired biophysical, functional, and pharmacological properties.

Discover more about 20n Bio

Xiaole C’s Colleagues

Xianguo Kong

Malvern, Pennsylvania, United States

MD, PhD

Principal Scientist, Head of technology development at 20n Bio
(December 2023 – Present)

Shuai Ye

Greater Philadelphia

Senior Scientist at 20n Bio

Senior Scientist at 20n Bio
(Present)

Linghang Zhuang

Fort Washington, Pennsylvania, United States

President, 20n Bio

President at 20n Bio
(Feb 2024 – Present)

Mingfu Zhu

Wayne, Pennsylvania, United States

Founder and CEO @ 20n Bio | Drug Hunter

We specialize in cyclic peptide drug discoveries, with various applications in oral peptides, radioligand therapies, and PDCs.
We are a Bayer Co.Lab portfolio company.
Seed I, $3.3M, Dec 2021, Bluerun Ventures China.
Seed II, $7.5M, Dec 2025, Strategic Investment.